Hunter Associates Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $914K | Buy |
15,806
+345
| +2% | +$19.8K | 0.11% | 153 |
|
|
2026
Q1 | $936K | Buy |
15,461
+1,199
| +8% | +$69.9K | 0.12% | 144 |
|
|
2025
Q4 | $767K | Buy |
14,262
+168
| +1% | +$8.08K | 0.1% | 150 |
|
|
2025
Q3 | $639K | Sell |
14,094
-3,142
| -18% | -$147K | 0.09% | 165 |
|
|
2025
Q2 | $800K | Sell |
17,236
-1,146
| -6% | -$56.3K | 0.12% | 148 |
|
|
2025
Q1 | $1.12M | Buy |
18,382
+3
| +0% | +$175 | 0.17% | 114 |
|
|
2024
Q4 | $1.04M | Buy |
18,379
+504
| +3% | +$28.2K | 0.16% | 121 |
|
|
2024
Q3 | $924K | Sell |
17,875
-436
| -2% | -$20.5K | 0.14% | 138 |
|
|
2024
Q2 | $759K | Sell |
18,311
-51,857
| -74% | -$2.32M | 0.13% | 144 |
|
|
2024
Q1 | $3.8M | Buy |
70,168
+4,807
| +7% | +$245K | 0.64% | 35 |
|
|
2023
Q4 | $3.35M | Sell |
65,361
-868
| -1% | -$45.6K | 0.61% | 42 |
|
|
2023
Q3 | $3.85M | Buy |
66,229
+4,176
| +7% | +$256K | 0.78% | 32 |
|
|
2023
Q2 | $3.96M | Buy |
62,053
+3,408
| +6% | +$229K | 0.77% | 32 |
|
|
2023
Q1 | $4.06M | Buy |
58,645
+5,914
| +11% | +$417K | 0.87% | 31 |
|
|
2022
Q4 | $3.8M | Sell |
52,731
-6,884
| -12% | -$519K | 0.92% | 28 |
|
|
2022
Q3 | $4.24M | Sell |
59,615
-78
| -0.1% | -$5.66K | 1.1% | 23 |
|
|
2022
Q2 | $4.6M | Buy |
59,693
+17,897
| +43% | +$1.36M | 1.14% | 21 |
|
|
2022
Q1 | $3.05M | Buy |
41,796
+9,089
| +28% | +$610K | 0.98% | 24 |
|
|
2021
Q4 | $2.04M | Buy |
32,707
+6,000
| +22% | +$352K | 0.58% | 40 |
|
|
2021
Q3 | $1.58M | Sell |
26,707
-12,000
| -31% | -$790K | 0.51% | 40 |
|
|
2021
Q2 | $2.59M | Sell |
38,707
-15,635
| -29% | -$1.02M | 0.81% | 31 |
|
|
2021
Q1 | $3.43M | Buy |
54,342
+834
| +2% | +$51.9K | 0.79% | 32 |
|
|
2020
Q4 | $3.32M | Sell |
53,508
-1,214
| -2% | -$74.6K | 0.82% | 30 |
|
|
2020
Q3 | $3.3M | Buy |
54,722
+1,284
| +2% | +$77.3K | 0.92% | 29 |
|
|
2020
Q2 | $3.14M | Sell |
53,438
-1,402
| -3% | -$83.9K | 0.93% | 29 |
|
|
2020
Q1 | $3.06M | Buy |
54,840
+431
| +0.8% | +$26.3K | 1.18% | 22 |
|
|
2019
Q4 | $3.49M | Buy |
54,409
+35,901
| +194% | +$2.06M | 1.08% | 25 |
|
|
2019
Q3 | $939K | Buy |
18,508
+115
| +0.6% | +$5.41K | 0.32% | 63 |
|
|
2019
Q2 | $834K | Hold |
18,393
| – | – | 0.29% | 72 |
|
|
2019
Q1 | $878K | Buy |
18,393
+685
| +4% | +$34.1K | 0.31% | 69 |
|
|
2018
Q4 | $920K | Hold |
17,708
| – | – | 0.37% | 63 |
|
|
2018
Q3 | $1.1M | Hold |
17,708
| – | – | 0.38% | 64 |
|
|
2018
Q2 | $980K | Hold |
17,708
| – | – | 0.35% | 63 |
|
|
2018
Q1 | $1.12M | Sell |
17,708
-780
| -4% | -$50.2K | 0.42% | 57 |
|
|
2017
Q4 | $1.13M | Buy |
18,488
+780
| +4% | +$48.8K | 0.42% | 58 |
|
|
2017
Q3 | $1.13M | Sell |
17,708
-250
| -1% | -$14.6K | 0.44% | 58 |
|
|
2017
Q2 | $1M | Sell |
17,958
-333
| -2% | -$18.1K | 0.41% | 56 |
|
|
2017
Q1 | $995K | Sell |
18,291
-360
| -2% | -$19.7K | 0.42% | 57 |
|
|
2016
Q4 | $1.09M | Hold |
18,651
| – | – | 0.47% | 53 |
|
|
2016
Q3 | $1.01M | Buy |
18,651
+200
| +1% | +$12.8K | 0.43% | 56 |
|
|
2016
Q2 | $1.36M | Sell |
18,451
-1,000
| -5% | -$70.7K | 0.59% | 48 |
|
|
2016
Q1 | $1.24M | Hold |
19,451
| – | – | 0.57% | 50 |
|
|
2015
Q4 | $1.34M | Hold |
19,451
| – | – | 0.59% | 47 |
|
|
2015
Q3 | $1.15M | Hold |
19,451
| – | – | 0.54% | 48 |
|
|
2015
Q2 | $1.29M | Hold |
19,451
| – | – | 0.54% | 49 |
|
|
2015
Q1 | $1.25M | Sell |
19,451
-3,200
| -14% | -$200K | 0.49% | 50 |
|
|
2014
Q4 | $1.34M | Sell |
22,651
-600
| -3% | -$33.8K | 0.51% | 49 |
|
|
2014
Q3 | $1.19M | Sell |
23,251
-1,266
| -5% | -$63.2K | 0.46% | 56 |
|
|
2014
Q2 | $1.19M | Sell |
24,517
-3,491
| -12% | -$172K | 0.47% | 56 |
|
|
2014
Q1 | $1.46M | Sell |
28,008
-13,800
| -33% | -$734K | 0.57% | 40 |
|
|
2013
Q4 | $2.22M | Sell |
41,808
-2,561
| -6% | -$130K | 0.86% | 34 |
|
|
2013
Q3 | $2.05M | Sell |
44,369
-1,530
| -3% | -$67.2K | 0.86% | 34 |
|
|
2013
Q2 | $2.05M | Buy |
+45,899
| New | +$1.99M | 0.76% | 33 |
|
Other funds holding BMY
AIM
FWIA
DLA
Hunter Associates Investment Management's BMY Position: Q2 2026 in Review
Hunter Associates Investment Management increased its Bristol-Myers Squibb (BMY) stake by 2.2% in Q2 2026, buying an estimated $19.8K and bringing the position to 15,806 shares worth $914K. The position accounts for 0.11% of the portfolio, ranked #153.
Hunter Associates Investment Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.6M in Q2 2022. 954 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Hunter Associates Investment Management held 15,806 shares of Bristol-Myers Squibb worth $914K as of Q2 2026.
- Hunter Associates Investment Management bought 345 Bristol-Myers Squibb shares in Q2 2026, an estimated $19.8K.
- Bristol-Myers Squibb made up 0.11% of Hunter Associates Investment Management's portfolio in Q2 2026, its #153 holding.
- Hunter Associates Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Hunter Associates Investment Management's Bristol-Myers Squibb position peaked at $4.6M in Q2 2022.
- 954 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.